Trial Profile
Phase II trial of docosahexaenoic acid-sodium salicylate conjugate [CAT 1004] in patients with inflammatory bowel disorders
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 26 Jul 2022
Price :
$35
*
At a glance
- Drugs Edasalonexent (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 13 Feb 2013 New trial record